Skip to main content

Is ATAI Stock a Buy After the IPO?

ATAI Life Sciences will go public this week. And investors wanting to cash in on one of the hottest medicine and mental health trends need to pay attention to this stock. The ATAI IPO will raise around $100 million that the company can add to its already-sizeable cash on hand, about $97 billion as of the end of 2020. ATAI stock could be the biggest psychedelic stock opportunity on the NASDAQ to date. This trend will continue to grow with further research into psychedelics for mental health treatment. Right now, it's just the beginning... Tags: IPOs The post Is ATAI Stock a Buy After the IPO? appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.